Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new travatan clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on travatan
- Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health
Status: Recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Ocular Hypertension; Open-Angle Glaucoma - Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Suspended, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - Travatan Versus Timoptic in Treating Open-Angle Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Glaucoma - Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
Status: Recruiting, Condition Summary: Glaucoma; Ocular Hypertension - Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus Cosopt
Status: Recruiting, Condition Summary: Glaucoma; Ocular Hypertension - Travaprost 0.004% Versus Pilocarpine 1% in Patients With CACG
Status: Completed, Condition Summary: Angle-Closure Glaucoma - Safety and Efficacy of Travoprost/Timolol BAC-Free
Status: Recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - Azopt Plus Travatan in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
Status: Terminated, Condition Summary: Intraocular Pressure - Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - Phase IV Randomised Double-Masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - 24-Hour IOP Control With Travoprost/Timolol Fixed Combination
Status: Completed, Condition Summary: Primary Open Angle Glaucoma; Exfoliation Syndrome - 24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination (TTFC) Versus Travoprost When Both Are Given PM in Subjects With Primary Open-Angle Glaucoma (POAG)
Status: Completed, Condition Summary: Glaucoma - 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
Status: Active, not recruiting, Condition Summary: Glaucoma - Value of an Intervention to Enhance Adherence in Glaucoma Patients
Status: Active, not recruiting, Condition Summary: Glaucoma - Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
Status: Completed, Condition Summary: Glaucoma, Open-Angle; Ocular Hypertension - Phase IV Study of TRAVATAN 0.004% in Subjects With Iris Pigmentation Changes
Status: Recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - A Long-Term Safety Study of Once-Daily Travatan
Status: Active, not recruiting, Condition Summary: Glaucoma, Open-Angle; Ocular Hypertension - A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Status: Completed, Condition Summary: Glaucoma, Open-Angle; Ocular Hypertension - A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
Status: Completed, Condition Summary: Glaucoma, Angle-Closure; Ocular Hypertension - Safety and IOP Lowering Efficacy of AL-6221
Status: Completed, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-Angle Glaucoma (OAG)
Status: Active, not recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - Ocular Surface Effects of Prostaglandin Analogues (PGAs)
Status: Not yet recruiting, Condition Summary: Glaucoma - The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
Status: Recruiting, Condition Summary: Glaucoma; Periocular Skin Pigmentation Changes - Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Primary Open-Angle Glaucoma; Ocular Hypertension; Pigment Dispersion Glaucoma - Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
Status: Completed, Condition Summary: Primary Open Angle Glaucoma; Ocular Hypertension - Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
Status: Recruiting, Condition Summary: Open Angle Glaucoma; Ocular Hypertension - A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Not yet recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension